Minimal change nephrotic syndrome four days after the administration of Pfizer-BioNTech COVID-19 vaccine-a new side effect or coincidence?

被引：11
|
作者：
Abdulgayoom, Mohammed [1 ]
Albuni, Mhd Kutaiba [1 ]
Abdelmahmuod, Elabbass [1 ]
Murshed, Khaled [2 ]
Eldeeb, Yassir [3 ]
机构：
[1] Hamad Med Corp, Dept Internal Med, Al Rayyan Rd,Box 3050, Doha, Qatar
[2] Hamad Med Corp, Div Anat Pathol, Doha, Qatar
[3] Hamad Med Corp, Dept Infect Dis, Doha, Qatar
来源：
CLINICAL CASE REPORTS | 2021年 / 9卷 / 10期
关键词：
COVID-19; minimal change disease; nephrotic syndrome; CHANGE DISEASE;
D O I：
10.1002/ccr3.5003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The association between the COVID vaccine and MCD is temporal and by exclusion, and it is not fully established, but it should be considered in postvvaccine MCD.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Myocardial injury after 4th dose of Pfizer-BioNTech COVID-19 vaccine
    Reactions Weekly, 2022, 1925 (1) : 10 - 10
  • [42] Management of cardiovascular symptoms after Pfizer-BioNTech COVID-19 vaccine in teenagers in the emergency department
    Liao, Ying-Feng
    Tseng, Wei-Chieh
    Wang, Jou-Kou
    Chen, Yih-Sharng
    Chen, Chun-An
    Lin, Ming-Tai
    Lu, Chun-Wei
    Wu, Mei-Hwan
    Chiu, Shuenn-Nan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (08) : 699 - 706
  • [43] Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine
    Tay, Carol
    Lai, Damien
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (09) : 589 - 589
  • [44] Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases
    Massimo Petruzzi
    Sara Galleggiante
    Sabrina Messina
    Fedora della Vella
    BMC Oral Health, 22
  • [45] Bullous pemphigoid with subsequent milia en plaque following administration of the Pfizer-BioNTech COVID-19 vaccine
    Murryam, Saerrah
    Panagou, Evangelia
    Martyn-Simmons, Claire
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (06) : E254 - E255
  • [46] Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine
    Giuffrida, Gaetano
    Condorelli, Annalisa
    Di Giorgio, Mary Ann
    Markovic, Uros
    Sciortino, Roberta
    Nicolosi, Daniela
    Di Raimondo, Francesco
    HAEMATOLOGICA, 2022, 107 (04) : 1008 - 1010
  • [47] Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases
    Petruzzi, Massimo
    Galleggiante, Sara
    Messina, Sabrina
    della Vella, Fedora
    BMC ORAL HEALTH, 2022, 22 (01)
  • [48] COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine COMMENT & RESPONSE
    Cohen, Kenneth R.
    JAMA INTERNAL MEDICINE, 2022, 182 (06) : 687 - 688
  • [49] A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barre Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine
    Yamada, Shunsuke
    Yamada, Kanako
    Nishida, Hiroshi
    INTERNAL MEDICINE, 2022, 61 (19) : 2995 - 2995
  • [50] Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series
    Corbeddu, M.
    Diociaiuti, A.
    Vinci, M. R.
    Santoro, A.
    Camisa, V.
    Zaffina, S.
    El Hachem, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (08) : E483 - E485
12345